BEIJING, Oct. 13 (Xinhua) -- China's securities regulator has given the green light to the registration-based initial public offering (IPO) of five companies on the science and technology innovation board.
Suzhou BrightGene Bio-Medical Technology Co., Ltd., Shandong Aofu Environmental Technology Co., Ltd., Shanghai Medicilon Inc., Ningbo Solartron Technology Co., Ltd and Tianjin Jiuri New Materials Co., Ltd., will be listed on the Shanghai Stock Exchange's sci-tech innovation board, commonly known as the STAR market, the China Securities Regulatory Commission said in a statement.
The companies and their underwriters will confirm the IPO dates and publish their prospectuses following discussions with the stock exchange.
The STAR market, inaugurated in June and designed to focus on companies in the high-tech and strategic emerging sectors, eases the listing criteria but adopts higher requirements for information disclosure.
A single purchase
